00:20:46Canada

Abbott Laboratories (ABT)

NYSE

Key stats Fiscal year 2025

Income statement

Revenue
44,328,000,000 5.7%
Net income
6,524,000,000 -51.3%
Operating income
8,053,000,000
Earnings per share
3.73 -51.4%
R&D expense
2,942,000,000

Growth and profitability

Operating margin
18.17
Net margin
14.72
Return on equity
12.51
Return on assets
7.52
Free cash flow margin
16.68

Balance sheet

Total assets
86,713,000,000
Shareholders' equity
52,130,000,000
Cash and equivalents
8,522,000,000
Debt
12,929,000,000
Net debt
4,407,000,000
Current ratio
1.58
Debt to equity
0.25

Cash flow and ratios

Operating cash flow
9,566,000,000
Free cash flow
7,395,000,000

Shareholder returns

Dividend per share
2.40
Dividends paid
4,116,000,000
Share buybacks
893,000,000
Shares outstanding
1,731,941,601
Book value per share
30.10
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Abbott Park, IL
Exchange
NYSE
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Abbott Laboratories trades on NYSE under the ticker symbol ABT. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis